Study of kaempferol in the treatment of COVID-19 combined with Chikungunya co-infection by network pharmacology and molecular docking technology

Chikungunya (CHIK) patients may be vulnerable to coronavirus disease (COVID-19). However, presently there are no anti-COVID-19/CHIK therapeutic alternatives available. The purpose of this research was to determine the pharmacological mechanism through which kaempferol functions in the treatment of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Md Arju, Sohel, Md, Sultana, Tayeba, Hasan, Md Imran, Khan, Md Sharif, Kibria, K.M. Kaderi, Mahmud, S.M. Hasan, Rahman, Md Habibur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264333/
https://www.ncbi.nlm.nih.gov/pubmed/37346467
http://dx.doi.org/10.1016/j.imu.2023.101289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264333/
https://www.ncbi.nlm.nih.gov/pubmed/37346467
http://dx.doi.org/10.1016/j.imu.2023.101289

Ejemplares similares